Get startedLog in
    Picture of Pharmaids Pharmaceuticals logo

    524572 — Pharmaids Pharmaceuticals Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Pharmaids Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    R2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line1.4-99.1-156-173-163
    Depreciation
    Non-Cash Items00.30621.623.72.48
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-4.0958.411.2-26.499.7
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-2.59-40.2-106-151-40.6
    Capital Expenditures—-16.7-229-125-44.7
    Purchase of Fixed Assets
    Other Investing Cash Flow Items4.67-32.7-5212.57278
    Acquisition of Business
    Sale of Fixed Assets
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities4.67-49.4-750-122233
    Financing Cash Flow Items00-12.4-17-14.4
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities0213777234-200
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash2.07123-79.5-39.8-6.89